CASI Pharmaceuticals, Inc.
Records under this name other than the patents CASI Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Showing 1 to 3 of 3 · Back to CASI Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,399,440 | Disease modifying anti-arthritic activity of 2-methoxyestradiol Lapsed on the fee record Ended Mar 19, 2025 · USPTO record | Lapsed on the fee record | Ended Mar 19, 2025 | USPTO record |
| US 7,087,592 | Compositions comprising purified 2-methoxyestradiol and methods of producing same Term ended Term ended Mar 12, 2022 · USPTO record | Term ended | Term ended Mar 12, 2022 | USPTO record |
| US 7,235,540 | Methods of using 2-methoxyestradiol of high purity Term ended Ended no later than Aug 23, 2020 · USPTO record | Term ended | Ended no later than Aug 23, 2020 | USPTO record |